Pain
Conference Coverage
Is Meningitis a Risk Factor for Trigeminal Neuralgia? New Data
In multivariate analysis, the odds of meningitis were threefold higher in patients admitted with trigeminal neuralgia than in matched controls...
Latest News
The DEA Plans to Reschedule Marijuana: What Happens Next?
Following 2023 FDA information that legitimized marijuana as a medical treatment, DEA moves to lower its scheduling.
Conference Coverage
Semaglutide Trial for Knee Osteoarthritis Shows Improvements in Pain, Physical Function
Results of the STEP 9 study in people with knee osteoarthritis and obesity show that semaglutide not only induced significant weight loss but also...
From the Journals
Chronic Pain Linked to Accelerated Brain Aging
The acceleration in brain aging was largely driven by the hippocampus and predicted memory decline and incident dementia during follow-up.
From the Journals
PT Delivered Via Telemedicine Proves Noninferior to In-Person Care for Chronic Knee Pain
The results are a “game changer” for physical therapy, one expert said, and could help expand access to physiotherapy services for an underserved...
Latest News
‘Deep Phenotyping’ Identifies Abnormalities in ME/CFS
Underlying pathophysiology shows autonomic, immune, and metabolic dysfunction.
Latest News
Utility of NSAID Response Called Into Question for Longstanding AxSpA
New study finds no difference in long-term back pain from axSpA treated with NSAIDs and non-axSpA back pain.
Latest News
No Impact of Legalized Cannabis on Opioid Prescriptions, Mortality
However, investigators found that recreational cannabis laws may be tied to a potential reduction in synthetic opioid deaths.
Commentary
How to Motivate Pain Patients to Try Nondrug Options
Offer an interdisciplinary, integrative approach: acupuncture, acupressure, mindfulness, cognitive behavioral therapy, yoga, or tai chi may help...
From the Journals
Chronic Fatigue Syndrome and Fibromyalgia: A Single Disease Entity?
“The sum of these results does not support the hypothesis that ME/CFS and ME/CFS+FM are distinct entities, as currently defined.”
Latest News
Comments Disputed on Negative Low-Dose Naltrexone Fibromyalgia Trial
Neuroinflammation expert Jarred Younger, PhD, disputes commentary calling for clinicians to stop prescribing the off-label compounded medication...